New research identifies genetic variants that double the risk of blood clots in African Americans

A new study finds common genetic variants frequently documented in African Americans that doubles their risk of blood clots, according to Blood, the journal of the American Society of Hematology.

"While African Americans have a high risk for VTE, previous studies have not specifically focused on this population," said the study's senior author Minoli Perera, PhD, of the University of Chicago. African Americans are 30 to 60 percent more likely to suffer from venous thromboembolism. That's higher than all other U.S. populations.

Researchers led by Dr. Perera genotyped DNA samples from 578 African Americans to determine what genetic variants were highly prevalent. The researchers identified an association between three variants tied to a protein that regulates clotting and VTE. With the help of previously collected data, researchers found the percentages of these particular variants were much lower in other ethnicities.

"This study not only brings us closer to understanding the cause of VTE in African Americans, it demonstrates the importance of conducting population-specific research in precision medicine," said Dr. Perera.

More articles on quality: 
After a stroke, majority of patients want video conferencing with physicians 
Common antibiotics linked to seizures, hallucinations for infection patient 
The rise of the patient sitter — one of healthcare's most undervalued safety tools

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars